2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Published on Sep 10, 2019in Journal of the American College of Cardiology20.589
· DOI :10.1161/CIR.0000000000000677
Donna K. Arnett100
Estimated H-index: 100
,
Roger S. Blumenthal107
Estimated H-index: 107
+ 15 AuthorsBoback Ziaeian20
Estimated H-index: 20
Sources
Abstract
Author(s): Arnett, Donna K; Blumenthal, Roger S; Albert, Michelle A; Buroker, Andrew B; Goldberger, Zachary D; Hahn, Ellen J; Himmelfarb, Cheryl D; Khera, Amit; Lloyd-Jones, Donald; McEvoy, J William; Michos, Erin D; Miedema, Michael D; Munoz, Daniel; Smith, Sidney C; Virani, Salim S; Williams, Kim A; Yeboah, Joseph; Ziaeian, Boback
Figures & Tables
Download
📖 Papers frequently viewed together
355 Citations
6,730 Citations
683 Citations
References424
Newest
#1Scott M. GrundyH-Index: 212
#2Neil J. StoneH-Index: 56
Last. Joseph YeboahH-Index: 29
view all 24 authors...
Glenn N. Levine, MD, FACC, FAHA, Chair Patrick T. O’Gara, MD, MACC, FAHA, Chair-Elect Jonathan L. Halperin, MD, FACC, FAHA, Immediate Past Chair [‡‡‡][1] Sana M. Al-Khatib, MD, MHS, FACC, FAHA Joshua A. Beckman, MD, MS, FAHA Kim K. Birtcher, PharmD, MS, AACC Biykem Bozkurt, MD, PhD,
1,903 CitationsSource
#2Marieke De Craemer (UGent: Ghent University)H-Index: 19
Last. Emmanuel Stamatakis (USYD: University of Sydney)H-Index: 91
view all 8 authors...
Aim To assess the relationship between time spent in light physical activity and cardiometabolic health and mortality in adults. Design Systematic review and meta-analysis. Data sources Searches in Medline, Embase, PsycInfo, CINAHL and three rounds of hand searches. Eligibility criteria for selecting studies Experimental (including acute mechanistic studies and physical activity intervention programme) and observational studies (excluding case and case–control studies) conducted in adults (aged ...
123 CitationsSource
Abstract Background The cardiovascular safety profile of dapagliflozin, a selective inhibitor of sodium–glucose cotransporter 2 that promotes glucosuria in patients with type 2 diabetes, is undefined. Methods We randomly assigned patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease to receive either dapagliflozin or placebo. The primary safety outcome was a composite of major adverse cardiovascular events (MACE), defined as cardiovascular death, myocar...
2,030 CitationsSource
#1Thomas A Zelniker (Brigham and Women's Hospital)H-Index: 16
#2Stephen D. Wiviott (Brigham and Women's Hospital)H-Index: 86
Last. Marc S. Sabatine (Brigham and Women's Hospital)H-Index: 119
view all 15 authors...
Summary Background The magnitude of effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on specific cardiovascular and renal outcomes and whether heterogeneity is based on key baseline characteristics remains undefined. Methods We did a systematic review and meta-analysis of randomised, placebo-controlled, cardiovascular outcome trials of SGLT2i in patients with type 2 diabetes. We searched PubMed and Embase for trials published up to Sept 24, 2018. Data search and extraction were compl...
1,103 CitationsSource
James L. Januzzi Jr, MD, FACC, Chair Tariq Ahmad, MD, MPH, FACC Brendan Everett, MD, FACC William Hucker, MD, PhD Dharam J. Kumbhani, MD, SM, FACC Joseph E. Marine, MD, FACC Pamela B. Morris, MD, FACC Robert N. Piana, MD, FACC Sunil V. Rao, MD, FACC Marielle Scherrer-Crosbie, MD, PhD
86 CitationsSource
#1Joshua D. Mitchell (WashU: Washington University in St. Louis)H-Index: 15
#2Nicole Fergestrom (MCW: Medical College of Wisconsin)H-Index: 4
Last. Todd C. Villines (Walter Reed National Military Medical Center)H-Index: 51
view all 9 authors...
Abstract Background Compared with traditional risk factors, coronary artery calcium (CAC) scores improve prognostic accuracy for atherosclerotic cardiovascular disease (ASCVD) outcomes. However, the relative impact of statins on ASCVD outcomes stratified by CAC scores is unknown. Objectives The authors sought to determine whether CAC can identify patients most likely to benefit from statin treatment. Methods The authors identified consecutive subjects without pre-existing ASCVD or malignancy who...
96 CitationsSource
#1Mahshid Dehghan (Population Health Research Institute)H-Index: 26
#2Andrew Mente (McMaster University)H-Index: 39
Last. Salim Yusuf (Independence University)H-Index: 247
view all 39 authors...
Summary Background Dietary guidelines recommend minimising consumption of whole-fat dairy products, as they are a source of saturated fats and presumed to adversely affect blood lipids and increase cardiovascular disease and mortality. Evidence for this contention is sparse and few data for the effects of dairy consumption on health are available from low-income and middle-income countries. Therefore, we aimed to assess the associations between total dairy and specific types of dairy products wi...
159 CitationsSource
#1Katrina L. Piercy (HHS: United States Department of Health and Human Services)H-Index: 15
#2Richard P. Troiano (HHS: United States Department of Health and Human Services)H-Index: 65
Last. Richard D Olson (HHS: United States Department of Health and Human Services)H-Index: 4
view all 8 authors...
Importance Approximately 80% of US adults and adolescents are insufficiently active. Physical activity fosters normal growth and development and can make people feel, function, and sleep better and reduce risk of many chronic diseases. Objective To summarize key guidelines in the Physical Activity Guidelines for Americans , 2nd edition (PAG). Process and Evidence Synthesis The 2018 Physical Activity Guidelines Advisory Committee conducted a systematic review of the science supporting physical ac...
2,145 CitationsSource
Summary Background Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patien...
655 CitationsSource
#2Louise BowmanH-Index: 21
#3Marion MafhamH-Index: 14
Last. Jane ArmitageH-Index: 60
view all 27 authors...
© 2018 Massachusetts Medical Society. Background: Diabetes mellitus is associated with an increased risk of cardiovascular events. Aspirin use reduces the risk of occlusive vascular events but increases the risk of bleeding; the balance of benefits and hazards for the prevention of first cardiovascular events in patients with diabetes is unclear. Methods: We randomly assigned adults who had diabetes but no evident cardiovascular disease to receive aspirin at a dose of 100 mg daily or matching pl...
464 CitationsSource
Cited By1300
Newest
#1Vahid Rezvanizadeh (Los Angeles Biomedical Research Institute)H-Index: 1
#2Matthew J. Budoff (UCLA: University of California, Los Angeles)H-Index: 138
Source
#1Li Dong (Xi'an Jiaotong University)
#2Zhang Bing (Xi'an Jiaotong University)
Last. Li Geng (Xi'an Jiaotong University)H-Index: 10
view all 10 authors...
Abstract null null A mechanically flexible and fully integrated electrocardiogram (ECG) recording patch (ERP) that simultaneously monitors the ECG signals and detects the arrhythmia is presented. A simplified two-step process is applied to fabricate the acetylene carbon black (AB)/ polydimethylsiloxane (PDMS) electrodes. The soft and adhesive nature of polymer composite electrodes allows conformal contact to the skin. The ERP integrates ECG front end circuits, microcontroller chip and wireless c...
Source
#3Olufunmilayo H. Obisesan (MedStar Union Memorial Hospital)H-Index: 5
Abstract null null Objective null : Aspirin has been widely utilized over several decades for atherosclerotic cardiovascular disease (ASCVD) prevention among adults in the United States. We examined trends in aspirin use among adults aged ≥40 years from 1998 to 2019 and assessed factors associated with its use for primary and secondary ASCVD prevention. null null null Methods null : Using 1998–2019 Behavioral Risk Factor Surveillance System data, we obtained weighted prevalence of aspirin use am...
Source
#1Harry Klimis (USYD: University of Sydney)H-Index: 6
#2Aravinda Thiagalingam (USYD: University of Sydney)H-Index: 27
Last. Clara K. Chow (USYD: University of Sydney)H-Index: 55
view all 6 authors...
ABSTRACT null null Background null Primary prevention guidelines emphasise the importance of lifestyle modification, but many at high-risk have suboptimal cardiovascular risk factor (CVRF) control. Text message support may improve control, but the evidence is sparse. Our objective was to determine the impact of text messages on multiple CVRFs in a moderate-high risk primary prevention cohort. null null null Methods null This study was a single-blind randomised clinical trial comparing semi-perso...
Source
Last. Mahera AbdulrahmanH-Index: 13
view all 9 authors...
Source
#1Massimiliano Ruscica (University of Milan)H-Index: 35
#2Cesare R. Sirtori (University of Milan)H-Index: 72
Last. Amirhossein Sahebkar (MUMS: Mashhad University of Medical Sciences)H-Index: 104
view all 5 authors...
Abstract null null Over the last 10 years, there have been advances on several aspects of lipoprotein(a) which are reviewed in the present article. Since the standard immunoassays for measuring lipoprotein(a) are not fully apo(a) isoform-insensitive, the application of an LC-MS/MS method for assaying molar concentrations of lipoprotein(a) has been advocated. Genome wide association, epidemiological, and clinical studies have established high lipoprotein(a) as a causal risk factor for atheroscler...
Source
#1Carol Maher (UniSA: University of South Australia)H-Index: 48
#2Kimberley Szeto (UniSA: University of South Australia)H-Index: 1
Last. John B. Arnold (UniSA: University of South Australia)H-Index: 14
view all 3 authors...
BACKGROUND Wearable activity monitors (WAMs, e.g. Fitbits and research accelerometers) show promise for helping health care professionals (HCPs) measure and intervene on patients' activity patterns. This study aimed to describe the clinical use of WAMs within South Australia, barriers and enablers, and future opportunities for large-scale clinical use. METHODS A descriptive qualitative study was undertaken using semi-structured interviews. Participants were HCPs with experience using WAMs in Sou...
Source
#1Frances Wang (Johns Hopkins University)H-Index: 5
#2Chao Yang (Johns Hopkins University)H-Index: 7
Last. Josef Coresh (Johns Hopkins University)H-Index: 167
view all 11 authors...
Abstract null null Background and aims null The ankle-brachial index (ABI) is a diagnostic test for screening for and/or detecting peripheral artery disease (PAD), as well as a risk enhancer in the AHA/ACC guidelines on the primary prevention of atherosclerotic cardiovascular disease (ASCVD). However, our understanding of the association between ABI and cardiovascular risk in contemporary older populations is limited. Additionally, the prognostic value of ABI among individuals with prior ASCVD i...
Source
#1Jiang He (Tulane University)H-Index: 45
Importance null After decades of decline, the US cardiovascular disease mortality rate flattened after 2010, and racial and ethnic differences in cardiovascular disease mortality persisted. null Objective null To examine 20-year trends in cardiovascular risk factors in the US population by race and ethnicity and by socioeconomic status. null Design, Setting, and Participants null A total of 50 571 participants aged 20 years or older from the 1999-2018 National Health and Nutrition Examination Su...
Source
#1Catarina SchibornH-Index: 2
#2Tilman Kühn (DKFZ: German Cancer Research Center)H-Index: 40
Last. Matthias B. Schulze (University of Potsdam)H-Index: 98
view all 8 authors...
Inclusion of clinical parameters limits the application of most cardiovascular disease (CVD) prediction models to clinical settings. We developed and externally validated a non-clinical CVD risk score with a clinical extension and compared the performance to established CVD risk scores. We derived the scores predicting CVD (non-fatal and fatal myocardial infarction and stroke) in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort (n = 25,992, cases = 683) usin...
1 CitationsSource